Neurological complications of paroxysmal nocturnal hemoglobinuria

Canadian Journal of Neurological Sciences

Volumn 34, Issue 3, 2007, Pages 368-371

  Samadder, N Jewel ^a,b   Casaubon, Leanne ^a   Silver, Frank ^a   Cavalcanti, Rodrigo ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ANGIOPLASTY; ARTERY THROMBOSIS; ARTICLE; BRAIN HEMATOMA; BRAIN INFARCTION; CASE REPORT; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HOSPITALIZATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; STROKE;

EID: 34548418418     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100006855     Document Type: Article

References (30)

1. Rotoli B, Luzzatto I. Paroxysmal nocturnal hemoglobinuria. Baillierees Clin Haematol. 1989;2:13-38.
2. Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal hemoglobinuria: long-term follow-up and prognostic factors. French Society of Hematology. Lancet. 1996;348:573-7.
3. Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda J, et al. Paroxysmal nocturnal hemoglobinuria is caused by somatic mutations in the PIG-Agene. EMBO J. 1994;13:110-17.
4. Ware RE, Rosse WF, Howard TA. Mutations within the PIG-A gene in patients with paroxysmal nocturnal hemoglobinuria. Blood. 1994;83:2418-22.
5. Johnson RJ, Hillmen P. Paroxysmal nocturnal hemoglobinuria: nature's gene therapy? J Clin Pathol: Mol Pathol. 2002;55:145-52.
6. Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M, et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993;259:18-20.
7. Holguin MH, Wilcox LA, Bernshaw NJ, Rossse WF, Parker CJ. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1989;84:1387-94.
8. Nicholson-Weller A, March JP, Rosenfeld SI, Susten KF. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA. 1983;80:5066-70.
9. Miyata T, Yamada N, Iida Y, Nishimura J, Takeda J, Kitani T, et al. Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1994;330:249-55.
10. Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinurai. Blood. 1995;86:3277-86.
11. Rollins SA, Sims PJ. The complement inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol. 1990;144:3478-83.
12. Ham GD, Horack HM. Chronic haemolytic anaemia with paroxysmal nocturnal hemoglobinuria. Arch Intern Med. 1941;67:115-36.
13. Smith LJ. Paroxysmal nocturnal hemoglobinuria. Clin Lab Sci. 2004;17:172-7.
14. Peytremann RR, Hartmann RC. Thrombosis in paroxysmal nocturnal hemoglobinuria with particular reference to progressive, diffuse hepatic venous thrombosis. Set Haematol. 1972;3:115-36.
15. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinura. N Engl J Med. 1995;333:1253-8.
16. Johnson RV, Kaplan SR, Blailock ZR. Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria. Neurology. 1970;20:681-6.
17. Hartmann RC, Luter AB, Jenkins DR, Tenorio LE, Saba HI. Fulminant hepatic venous thrombosis (Budd-Chiari syndrome) in paroxysmal nocturnal hemoglobinuria: definition of medical emergency. Johns Hopkins Med J. 1980;146:247-54.
18. Valla D, Dhumeaus D, Babany G, Hillon P, Rueff B, Rochant H, et al. Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria: a spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology. 1987;93:569.
19. Klein KL, Hartmann RC. Acute coronary thrombosis in paroxysmal nocturnal hemoglobinuria. South Med J. 1989;82:1169-71.
20. Al-Samman MB, Cuetter AC. Cerebral arterial thrombosis as a complication of paroxysmal nocturnal hemoglobinuria. South Med J. 1994;87:1355-8.
21. Hyafil F, Montalescot G, Amoura Z, Choussat R, Collet JP, Piette JC. Recurrent myocardial infarction in a patient with paroxysmal nocturnal hemoglobinuria. Circulation. 2003;108: e91-e92.
22. Granata G, Izzo T, Di Micco P, Bonamassa B, Castaldo G, Viggiano VG, et al. Thromboembolic events and haematological diseases: a case of stroke as clinical onset of a paroxysmal nocturnal hemoglobinuria. Thrombosis Journal. 2004;2:10-14.
23. von Stuckrad-Barre S, Berkefeld J, Steckel D, Sitzer M. Cerebral arterial thrombosis in paroxysmal nocturnal hemoglobinuria. J Neurol. 2003;250:756-7.
24. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332-40.
25. Telen MJ, Green AM. The Inab phenotype: characterization of the membrane protein and complement regulatory defect. Blood. 1989;74:437-41.
26. Yamashina M, Ueda E, Kinoshita T, Takami T, Ojima A, Ono H, et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1990;323:1184-9.
27. Hall C, Richards S, Hillmen P. Primary prophylaxsis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria. Blood. 2003;102:3587-91.
28. Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;350: 522-9.
29. Kinoshita T, Inoue N. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Int J Hematol. 2002;75:117-22.
30. Bjorge L, Ernst P, Haram KO. Paroxysmal nocturnal hemoglobinuria in pregnancy. Acta Obstet Gynecol Sand. 2003;82:1067-71.